Enliven Therapeutics Management
Management criteria checks 2/4
Enliven Therapeutics' CEO is Sam Kintz, appointed in Jun 2019, has a tenure of 5.42 years. total yearly compensation is $8.28M, comprised of 6.8% salary and 93.2% bonuses, including company stock and options. directly owns 2.05% of the company’s shares, worth $24.95M. The average tenure of the management team and the board of directors is 3.3 years and 3.8 years respectively.
Key information
Sam Kintz
Chief executive officer
US$8.3m
Total compensation
| CEO salary percentage | 6.8% |
| CEO tenure | 5.4yrs |
| CEO ownership | 2.1% |
| Management average tenure | 3.3yrs |
| Board average tenure | 3.8yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$85m |
| Jun 30 2024 | n/a | n/a | -US$83m |
| Mar 31 2024 | n/a | n/a | -US$80m |
| Dec 31 2023 | US$8m | US$561k | -US$72m |
| Sep 30 2023 | n/a | n/a | -US$62m |
| Jun 30 2023 | n/a | n/a | -US$52m |
| Mar 31 2023 | n/a | n/a | -US$44m |
| Dec 31 2022 | US$724k | US$400k | -US$38m |
| Sep 30 2022 | n/a | n/a | -US$37m |
| Dec 31 2021 | US$2m | US$400k | -US$25m |
Compensation vs Market: Sam's total compensation ($USD8.28M) is above average for companies of similar size in the US market ($USD5.54M).
Compensation vs Earnings: Sam's compensation has increased whilst the company is unprofitable.
CEO
Sam Kintz (38 yo)
5.4yrs
Tenure
US$8,279,751
Compensation
Mr. Samuel S. Kintz, M.B.A., also known as Sam, is Co-Founder, CEO, Secretary & Director of Enliven Therapeutics, Inc. He has served as Former Enliven’s President and Chief Executive Officer and a Director...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 5.4yrs | US$8.28m | 2.05% $ 25.0m | |
| Co-Founder & Chief Scientific Officer | no data | US$4.01m | 2.08% $ 25.3m | |
| Chief Medical Officer | 3.3yrs | US$4.06m | no data | |
| Co-Founder & COO | 5.4yrs | no data | 0.70% $ 8.5m | |
| CFO & Head of Corporate Development | 3.3yrs | US$567.14k | no data | |
| Chief Legal Officer & Head of Business Development | 1.3yrs | no data | no data |
3.3yrs
Average Tenure
45yo
Average Age
Experienced Management: ELVN's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 5.4yrs | US$8.28m | 2.05% $ 25.0m | |
| Independent Director | 5.3yrs | US$538.26k | 0% $ 0 | |
| Independent Chairman | 3.7yrs | US$664.11k | 0.39% $ 4.7m | |
| Independent Director | less than a year | no data | 0.094% $ 1.1m | |
| Independent Director | 3.4yrs | US$551.21k | 0.18% $ 2.2m | |
| Director | 6.4yrs | US$1.87m | 0.046% $ 555.9k | |
| Independent Director | 3.9yrs | US$542.95k | 0% $ 0 | |
| Independent Director | 3.3yrs | US$541.48k | 0% $ 0 |
3.8yrs
Average Tenure
50yo
Average Age
Experienced Board: ELVN's board of directors are considered experienced (3.8 years average tenure).